Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.23.3
Consolidated Balance Sheets - USD ($)
Jun. 30, 2023
Jun. 30, 2022
Current assets:    
Cash $ 44,187 $ 280,877
Accounts receivable (net of allowance of $0 and $0, respectively) 33,396 93,674
Inventory 276,202 331,531
Other current asset 92,726 137,797
Total current assets 446,511 843,879
Total assets 446,511 843,879
Current liabilities:    
Accounts payable and accrued liabilities 604,516 234,152
Accounts payable and accrued liabilities - related party 101,876
Convertible notes payable - net of discounts 1,491,719 344,151
Total current liabilities 2,198,111 578,303
Commitments and contingencies
Stockholders’ equity (deficit):    
Total Stockholders’ Equity (Deficit) (1,751,600) 265,576
Total Liabilities and Stockholders’ Equity (Deficit) 446,511 843,879
Series A Preferred Stock    
Stockholders’ equity (deficit):    
Series of preferred stock 1 1
Common stock, $0.001 par value, 200,000,000 shares authorized 123,587,968 and 91,814,484 issued and outstanding as of June 30, 2023 and 2022, respectively 123,588 91,814
Additional paid in capital 33,112,935 28,275,216
Accumulated deficit (34,988,126) (28,101,458)
Series B Preferred Stock    
Stockholders’ equity (deficit):    
Series of preferred stock $ 2 $ 3